Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement

doi:10.1016/j.eururo.2018.09.019

Editorial

. 2019 Mar;75(3):408-409.

doi: 10.1016/j.eururo.2018.09.019. Epub 2018 Sep 27.

Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement

Rebecca E Graff¹, Linda Kachuri², John S Witte³

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. Electronic address: [email protected].
² Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.

PMID: 30268658
DOI: 10.1016/j.eururo.2018.09.019

Editorial

Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement

Rebecca E Graff et al. Eur Urol. 2019 Mar.

. 2019 Mar;75(3):408-409.

doi: 10.1016/j.eururo.2018.09.019. Epub 2018 Sep 27.

Authors

Rebecca E Graff¹, Linda Kachuri², John S Witte³

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. Electronic address: [email protected].
² Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.

PMID: 30268658
DOI: 10.1016/j.eururo.2018.09.019

No abstract available

PubMed Disclaimer

Comment on

Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA, Gerke T, Carlsson SV, Signorello L, Sjoberg DD, Markt SC, Kibel AS, Trinh QD, Steinwandel M, Blot W, Vickers AJ, Lilja H, Mucci LA, Wilson KM. Preston MA, et al. Eur Urol. 2019 Mar;75(3):399-407. doi: 10.1016/j.eururo.2018.08.032. Epub 2018 Sep 17. Eur Urol. 2019. PMID: 30237027 Free PMC article.

Cited by

The inhibitory effect of melatonin on human prostate cancer.
Shen D, Ju L, Zhou F, Yu M, Ma H, Zhang Y, Liu T, Xiao Y, Wang X, Qian K. Shen D, et al. Cell Commun Signal. 2021 Mar 15;19(1):34. doi: 10.1186/s12964-021-00723-0. Cell Commun Signal. 2021. PMID: 33722247 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

R25 CA112355/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement

Affiliations

Personalized Prostate Cancer Screening Based on a Single Midlife Prostate-specific Antigen Measurement

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical